© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Experimental models of torsade de pointes1
Hospital of the Westfälische Wilhelms-University, Department of Cardiology and Angiology and Institute for Arteriosclerosis Research, D-48129 Münster, Germany
* Corresponding author. Tel.: +49 (251) 834 7638, Fax: +49 (251) 834 7635, E-mail: l.eckardt@uni-muenster.de
Torsade de pointes is a potentially life threatening form of polymorphic ventricular tachycardia typically seen in the setting of congenital and acquired abnormal QT-prolongation. Numerous in vitro studies have investigated basic ionic mechanisms underlying delayed repolarization. The role of different ion channels and the induction of early afterdepolarizations have been studied in various cardiac cells including M cells. In addition, isolated heart models with and without electrical stimulation and/or the use of drugs which prolong repolarization have been developed in recent years. Some of these models have simulated conditions likely to exist in the clinical setting of torsade de pointes, such as bradycardia and hypokalemia. In in vivo canine and rabbit models, torsade-like polymorphic ventricular tachyarrhythmias have been induced by the administration of different agents such as cesium, neurotoxins, e.g., anthopleurin or various class III drugs under conditions designed to mimic the clinical situation. In the context of recent advances in the molecular genetics of long QT syndrome, those models which have used sodium or potassium channel blockers have gained particular interest. Based on all experimental studies it seems probable that the first beats of torsade occur due to early afterdepolarizations and triggered activity. The development of subsequent beats is less clear. Reentry based on inhomogeneity of refractoriness has been suggested as the underlying mechanism.
KEYWORDS Torsade de pointes; Experimental models; In vitro; In vivo; Long QT syndrome
1 Partly supported by the Franz Loogen Foundation, Düsseldorf, Germany.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Sims, S. Reisenweber, P. C. Viswanathan, B.-R. Choi, W. H. Walker, and G. Salama Sex, Age, and Regional Differences in L-Type Calcium Current Are Important Determinants of Arrhythmia Phenotype in Rabbit Hearts With Drug-Induced Long QT Type 2 Circ. Res., May 9, 2008; 102(9): e86 - e100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Milberg and L. Eckardt Transmural dispersion in LQT3 and arrhythmogenesis Cardiovasc Res, November 1, 2005; 68(2): 338 - 339. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Milan and C. A. MacRae Animal models for arrhythmias Cardiovasc Res, August 15, 2005; 67(3): 426 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Milberg, N. Reinsch, K. Wasmer, G. Monnig, J. Stypmann, N. Osada, G. Breithardt, W. Haverkamp, and L. Eckardt Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3 Cardiovasc Res, February 1, 2005; 65(2): 397 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Milan, T. A. Peterson, J. N. Ruskin, R. T. Peterson, and C. A. MacRae Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish Circulation, March 18, 2003; 107(10): 1355 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tsuji, T. Opthof, K. Yasui, Y. Inden, H. Takemura, N. Niwa, Z. Lu, J.-K. Lee, H. Honjo, K. Kamiya, et al. Ionic Mechanisms of Acquired QT Prolongation and Torsades de Pointes in Rabbits With Chronic Complete Atrioventricular Block Circulation, October 8, 2002; 106(15): 2012 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Milberg, L. Eckardt, H.-J. Bruns, J. Biertz, S. Ramtin, N. Reinsch, D. Fleischer, P. Kirchhof, L. Fabritz, G. Breithardt, et al. Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 218 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-R. Choi, F. Burton, and G. Salama Cytosolic Ca2+ triggers early afterdepolarizations and torsade de pointes in rabbit hearts with type 2 long QT syndrome J. Physiol., September 1, 2002; 543(2): 615 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Antzelevitch Sympathetic modulation of the long QT syndrome Eur. Heart J., August 2, 2002; 23(16): 1246 - 1252. [PDF]
|
|
|
|
 |
|
 R. Warth and J. Barhanin The multifaceted phenotype of the knockout mouse for the KCNE1 potassium channel gene Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R639 - R648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Eckardt, G. Breithardt, and W. Haverkamp Electrophysiologic Characterization of the Antipsychotic Drug Sertindole in a Rabbit Heart Model of Torsade de Pointes: Low Torsadogenic Potential Despite QT Prolongation J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 64 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sponer Prolongation of repolarization in pre-clinical investigations and phase I/II clinical trials: what should be done? Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K101 - K104. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Yamamoto, T. Tamura, R. Imai, and M. Yamamoto Acute Canine Model for Drug-Induced Torsades de Pointes in Drug Safety Evaluation--Influences of Anesthesia and Validation with Quinidine and Astemizole Toxicol. Sci., March 1, 2001; 60(1): 165 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Arrighi, M. Bloch-Faure, F. Grahammer, M. Bleich, R. Warth, R. Mengual, M.-D. Drici, J. Barhanin, and P. Meneton Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome PNAS, July 17, 2001; 98(15): 8792 - 8797. [Abstract] [Full Text] [PDF]
|
|